Master Class Report | API Industry – Marketing & Regulatory Aspects

MASTER CLASS REPORT

Marketing and Regulatory Aspects in the API Industry
by Mr. Srikant Prakash

Field Details
Speaker Mr. Srikant Prakash
Designation Associate Vice President – Head Sales & Marketing (API Division)
Organization Exemed Pharmaceuticals
Location Vadodara
Session Topic Marketing and Regulatory Aspects in the API Industry
Date April 10, 2026

1. Introduction

A master class was organised with Mr. Srikant Prakash, Associate Vice President and Head of Sales &
Marketing in the API division at Exemed Pharmaceuticals. The purpose of this session was to provide
students with a comprehensive understanding of the pharmaceutical industry's Active Pharmaceutical
Ingredient (API) sector.
The speaker shared valuable insights about API marketing strategies, regulatory compliance
frameworks, international market opportunities, and prevailing industry challenges. The session was
instrumental in helping students bridge the gap between academic learning and real-world
pharmaceutical business operations.

2. Understanding the API Industry

Active Pharmaceutical Ingredients (APIs) are the biologically active components in medicines that
produce the desired therapeutic effect. Pharmaceutical companies manufacture APIs and supply them
to formulation manufacturers, who then convert the APIs into finished dosage forms such as:
• Tablets and capsules
• Syrups and oral liquids
• Injectables and infusions
• Topical and transdermal formulations

Mr. Prakash explained that India has emerged as one of the leading global producers of APIs, driven by
its strong manufacturing infrastructure, highly skilled workforce, and competitive production costs.

For Academic Use Only | Exemed Pharmaceuticals – Guest Lecture | Page 1 of 6

 Master Class Report | API Industry – Marketing & Regulatory Aspects

Pharmaceutical companies across the world — particularly in the United States and Europe — rely
significantly on Indian manufacturers for high-quality, cost-effective APIs.

3. Marketing Strategies in the API Sector

Marketing in the API industry fundamentally differs from the marketing of finished pharmaceutical
products (FDFs). API marketing primarily follows a Business-to-Business (B2B) model, where
companies directly sell APIs to pharmaceutical formulation companies rather than to end consumers.

3.1 Key Factors Influencing API Marketing

• Consistent and certified product quality
• Competitive and transparent pricing
• Strong regulatory approvals (USFDA, EU GMP, WHO GMP)
• Reliable and resilient supply chain
• Long-term strategic partnerships with formulation companies

3.2 International Trade & Business Development

The speaker highlighted that pharmaceutical companies actively participate in international trade
exhibitions, pharma conferences, and B2B networking events to build relationships with global buyers
and expand their market footprint. Some key platforms include CPhI Worldwide, CPHI India, and
regional pharma expos.

4. Drug Master File (DMF)

One of the most important regulatory instruments discussed during the session was the Drug Master
File (DMF). A DMF is a submission to a regulatory authority that provides confidential, detailed
information about facilities, processes, or articles used in the manufacture, processing, packaging, and
storage of an API.

4.1 Key Contents of a DMF

# DMF Component Purpose
1 Manufacturing Process Description Documents step-by-step synthesis of the API
2 Raw Material Specifications Lists approved sources and quality standards
3 Quality Control Procedures Analytical methods, in-process & release
testing
4 Stability Studies Shelf-life data under various storage conditions
5 Packaging & Storage Conditions Container-closure systems and storage
requirements

For Academic Use Only | Exemed Pharmaceuticals – Guest Lecture | Page 2 of 6

 Master Class Report | API Industry – Marketing & Regulatory Aspects

Regulatory authorities evaluate DMFs as part of the new drug application (NDA) or abbreviated new
drug application (ANDA) review process before approving APIs for use in pharmaceutical production.
Robust and complete documentation is non-negotiable for companies intending to supply APIs to
regulated international markets.

For Academic Use Only | Exemed Pharmaceuticals – Guest Lecture | Page 3 of 6

 Master Class Report | API Industry – Marketing & Regulatory Aspects

5. USFDA Inspection Process

Mr. Prakash provided a detailed overview of the U.S. Food and Drug Administration (USFDA) and its
critical role in maintaining pharmaceutical quality standards worldwide. The USFDA is widely regarded
as the most stringent and influential pharmaceutical regulatory authority globally.

5.1 What the USFDA Inspects

• Manufacturing procedures and batch records
• Documentation systems and data integrity
• Equipment validation and calibration records
• Quality control laboratories and analytical systems
• Environmental monitoring in sterile manufacturing areas
• Corrective and Preventive Action (CAPA) systems

5.2 Outcome of USFDA Inspections

Companies that successfully pass USFDA inspections gain immense credibility and the ability to supply
APIs to the highly regulated and lucrative US pharmaceutical market. Conversely, companies that
receive Warning Letters or Import Alerts face serious commercial consequences including shipment
bans and market exclusion.

6. Regulatory Requirements in API Manufacturing

Regulatory compliance is the cornerstone of the pharmaceutical industry. API manufacturers must
strictly follow internationally recognised guidelines and quality standards throughout the production and
export process.

6.1 Key Regulatory Requirements

• GMP (Good Manufacturing Practices) certification from relevant authorities
• Regulatory filings including DMFs, CEPs (Certificate of Suitability), and dossiers
• Product registration in the importing country's regulatory database
• Compliance with ICH Q7 guidelines for API manufacturing
• Annual product reviews and change control management

6.2 Major Global Regulatory Authorities

Authority Region Key Requirement
USFDA United States 21 CFR Part 211, cGMP compliance
EMA / EDQM European Union CEP, EU GMP certification
WHO Global (developing WHO GMP prequalification

For Academic Use Only | Exemed Pharmaceuticals – Guest Lecture | Page 4 of 6

 Master Class Report | API Industry – Marketing & Regulatory Aspects

markets)
CDSCO India Schedule M compliance
PMDA Japan Japanese Pharmacopoeia standards

7. Global API Market Landscape

The speaker highlighted the rapidly growing demand for APIs across international markets. India has
established itself as the pharmacy of the world, supplying APIs to over 200 countries. Indian
pharmaceutical companies export APIs primarily to:
• United States – the largest regulated market for APIs
• Europe – stringent quality requirements but high-value contracts
• Latin America – growing healthcare infrastructure driving demand
• Southeast Asia & Africa – emerging markets with expanding access to medicines

India's competitive advantage in the global API market stems from its advanced pharmaceutical
manufacturing ecosystem, strong chemistry talent pool, established regulatory track record, and
government support through schemes like PLI (Production Linked Incentive) for the pharma sector.

8. Career Opportunities in the API Industry

Mr. Prakash dedicated a portion of the session to guiding students on career paths available in the
pharmaceutical and API sector. He emphasized that the industry offers diverse roles across technical,
commercial, and regulatory functions.

Career Domain Role Description

Regulatory Affairs Prepare and manage DMFs, dossiers, product registrations for global
markets
Quality Assurance Ensure GMP compliance, audit systems, manage CAPA and
documentation
Production & Manufacturing Oversee API synthesis, batch processing, yield optimization
Research & Development Develop new API processes, improve synthesis routes, impurity
profiling
International Sales & Business development, client acquisition, pricing strategy, trade shows
Marketing

Mr. Prakash advised students to build strong technical knowledge, stay updated on regulatory
developments, and develop professional communication and negotiation skills — all of which are critical
for career success in this sector.

For Academic Use Only | Exemed Pharmaceuticals – Guest Lecture | Page 5 of 6

 Master Class Report | API Industry – Marketing & Regulatory Aspects

9. Key Takeaways from the Session

• APIs are the foundation of all medicines — quality and compliance in API manufacturing directly
impact patient safety globally
• India is a dominant global API supplier, and the sector presents strong career and business
opportunities
• API marketing is B2B in nature and depends on regulatory approvals, supply reliability, and
trust-based relationships
• The Drug Master File (DMF) is a critical regulatory document — meticulous documentation is
essential for market access
• USFDA inspections are rigorous; passing them opens access to the world's largest
pharmaceutical market
• Career opportunities in the API industry span regulatory affairs, QA, R&D, manufacturing, and
international business
• Continuous learning, quality mindset, and regulatory awareness are key attributes for
professionals in this sector

10. Conclusion

The master class delivered by Mr. Srikant Prakash was highly informative and professionally enriching.
His real-world experience as a senior leader in pharmaceutical API sales and marketing brought
practical depth to the theoretical concepts students study in the classroom.
The session provided students with a clear understanding of how the API industry functions — from
manufacturing and quality compliance to global marketing and regulatory navigation. It also
underscored India's pivotal role in the global pharmaceutical supply chain and the wide spectrum of
career opportunities available for aspiring pharmaceutical professionals.
Students are encouraged to explore internship opportunities, follow USFDA and EMA regulatory
updates, and engage with industry publications to build a stronger foundation in this dynamic sector.

For Academic Use Only | Exemed Pharmaceuticals – Guest Lecture | Page 6 of 6